• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化 Prime/Boost 疫苗策略:训练免疫作为新的游戏玩家。

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.

机构信息

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

School of Medical Sciences, Kirby Institute for Infection and Immunity, Cellular Genomics Futures Institute, University of New South Wales, Sydney, NSW, Australia.

出版信息

Front Immunol. 2021 Mar 8;12:612747. doi: 10.3389/fimmu.2021.612747. eCollection 2021.

DOI:10.3389/fimmu.2021.612747
PMID:33763063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7982481/
Abstract

Most vaccines require multiple doses to induce long-lasting protective immunity in a high frequency of vaccines, and to ensure strong both individual and herd immunity. Repetitive immunogenic stimulations not only increase the intensity and durability of adaptive immunity, but also influence its quality. Several vaccine parameters are known to influence adaptive immune responses, including notably the number of immunizations, the delay between them, and the delivery sequence of different recombinant vaccine vectors. Furthermore, the initial effector innate immune response is key to activate and modulate B and T cell responses. Optimization of homologous and heterologous prime/boost vaccination strategies requires a thorough understanding of how vaccination history affects memory B and T cell characteristics. This requires deeper knowledge of how innate cells respond to multiple vaccine encounters. Here, we review how innate cells, more particularly those of the myeloid lineage, sense and respond differently to a 1st and a 2nd vaccine dose, both in an extrinsic and intrinsic manner. On one hand, the presence of primary specific antibodies and memory T cells, whose critical properties change with time after priming, provides a distinct environment for innate cells at the time of re-vaccination. On the other hand, innate cells themselves can exert enhanced intrinsic antimicrobial functions, long after initial stimulation, which is referred to as trained immunity. We discuss the potential of trained innate cells to be game-changers in prime/boost vaccine strategies. Their increased functionality in antigen uptake, antigen presentation, migration, and as cytokine producers, could indeed improve the restimulation of primary memory B and T cells and their differentiation into potent secondary memory cells in response to the boost. A better understanding of trained immunity mechanisms will be highly valuable for harnessing the full potential of trained innate cells, to optimize immunization strategies.

摘要

大多数疫苗需要多次接种才能在高频率的疫苗中诱导持久的保护性免疫,并确保个体和群体免疫力都很强。重复的免疫刺激不仅会增加适应性免疫的强度和持久性,还会影响其质量。有几个疫苗参数已知会影响适应性免疫反应,包括免疫接种的次数、接种之间的间隔以及不同重组疫苗载体的接种顺序。此外,初始效应性先天免疫反应对于激活和调节 B 细胞和 T 细胞反应至关重要。同源和异源初级/增强免疫接种策略的优化需要深入了解接种史如何影响记忆 B 和 T 细胞的特征。这需要更深入地了解先天细胞如何对多次疫苗接触做出反应。在这里,我们回顾了先天细胞,特别是髓系细胞,如何以外在和内在的方式不同地感知和响应第 1 次和第 2 次疫苗接种。一方面,初级特异性抗体和记忆 T 细胞的存在,其关键特性在初次免疫后随时间而变化,为再次接种时的先天细胞提供了一个独特的环境。另一方面,先天细胞本身可以在初次刺激后很长时间内发挥增强的内在抗菌功能,这被称为训练有素的免疫。我们讨论了训练有素的先天细胞在初级/增强疫苗策略中的潜在作用。它们在抗原摄取、抗原呈递、迁移和细胞因子产生方面的增强功能,确实可以改善对初级记忆 B 和 T 细胞的再刺激,并促进其分化为对增强剂有反应的有效次级记忆细胞。更好地了解训练有素的免疫机制对于充分利用训练有素的先天细胞潜力、优化免疫策略将具有很高的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5954/7982481/3754cb3a225c/fimmu-12-612747-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5954/7982481/cf5905f5c189/fimmu-12-612747-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5954/7982481/3754cb3a225c/fimmu-12-612747-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5954/7982481/cf5905f5c189/fimmu-12-612747-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5954/7982481/3754cb3a225c/fimmu-12-612747-g0002.jpg

相似文献

1
Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.优化 Prime/Boost 疫苗策略:训练免疫作为新的游戏玩家。
Front Immunol. 2021 Mar 8;12:612747. doi: 10.3389/fimmu.2021.612747. eCollection 2021.
2
Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting.疫苗免疫反应的转录组学:佐剂引发后增强可调节回忆性先天免疫反应。
Front Immunol. 2018 Jun 5;9:1248. doi: 10.3389/fimmu.2018.01248. eCollection 2018.
3
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response.初免-加强免疫策略可诱导独特的固有髓系细胞免疫应答。
Sci Rep. 2018 Feb 15;8(1):3087. doi: 10.1038/s41598-018-21222-2.
4
Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.使用基于多价修饰安卡拉疫苗病毒并以白细胞介素-15作为分子佐剂的高效持久抗结核初免/加强免疫方案。
Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.
5
Innate immune memory of tissue-resident macrophages and trained innate immunity: Re-vamping vaccine concept and strategies.组织驻留巨噬细胞和训练有素的先天免疫的先天免疫记忆:重塑疫苗概念和策略。
J Leukoc Biol. 2020 Sep;108(3):825-834. doi: 10.1002/JLB.4MR0220-446R. Epub 2020 Mar 3.
6
Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.用HIV-1膜近端外部区域-可变区3融合构建体进行初免/加强免疫可增强体液免疫和细胞免疫反应。
Immunol Lett. 2015 Dec;168(2):366-73. doi: 10.1016/j.imlet.2015.10.012. Epub 2015 Oct 27.
7
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.用于增强全身和黏膜免疫的基因异源初免-加强疫苗接种策略。
Expert Rev Vaccines. 2009 Sep;8(9):1171-81. doi: 10.1586/erv.09.86.
8
Jump-starting the immune system: prime-boosting comes of age.启动免疫系统:初免-加强免疫走向成熟。
Trends Immunol. 2004 Feb;25(2):98-104. doi: 10.1016/j.it.2003.11.009.
9
Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.肺内(i.pulmon.)接种结核亚单位疫苗候选株 H56/CAF01 加强免疫较单独肌肉(i.m.)或肺内(i.pulmon.)接种免疫能更显著地诱导固有免疫细胞和抗原提呈细胞的反应。
Front Immunol. 2020 May 7;11:803. doi: 10.3389/fimmu.2020.00803. eCollection 2020.
10
Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen.评价以 HER2 为模型抗原的重组腺病毒载体和佐剂蛋白作为异源初免-加强策略。
Vaccine. 2019 Nov 8;37(47):7029-7040. doi: 10.1016/j.vaccine.2019.08.079. Epub 2019 Sep 7.

引用本文的文献

1
Maladaptive trained immunity in viral infections.病毒感染中的适应性训练免疫
J Clin Invest. 2025 Sep 2;135(17). doi: 10.1172/JCI192469.
2
Generalized linear modeling of flow cytometry data to analyze immune responses in tuberculosis vaccine research.用于分析结核病疫苗研究中免疫反应的流式细胞术数据广义线性建模
NPJ Syst Biol Appl. 2025 Aug 10;11(1):90. doi: 10.1038/s41540-025-00572-4.
3
Vaccine Dosing Considerations in Product Labels and ACIP Recommendations: A Review.产品标签和美国免疫实践咨询委员会建议中的疫苗剂量考量:一项综述

本文引用的文献

1
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性:俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
2
Designing the Next Generation of Vaccines: Relevance for Future Pandemics.设计新一代疫苗:应对未来大流行的相关性。
mBio. 2020 Dec 22;11(6):e02616-20. doi: 10.1128/mBio.02616-20.
3
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
Vaccines (Basel). 2025 Jun 25;13(7):682. doi: 10.3390/vaccines13070682.
4
Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants.异源初免-加强免疫接种可驱动基质激活和针对新冠病毒变异株的适应性免疫。
Front Immunol. 2025 May 28;16:1597417. doi: 10.3389/fimmu.2025.1597417. eCollection 2025.
5
The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus.候选疫苗MVA-VP2-NS1-2A-NS2-Nt可使绵羊对蓝舌病毒产生异源保护。
Front Immunol. 2025 May 5;16:1566225. doi: 10.3389/fimmu.2025.1566225. eCollection 2025.
6
Impact of Extended Dosing Intervals and Ipsilateral Versus Contralateral Boosting on mRNA Vaccine Immunogenicity in Mice.延长给药间隔以及同侧与对侧加强免疫对小鼠mRNA疫苗免疫原性的影响
Vaccines (Basel). 2025 Mar 1;13(3):263. doi: 10.3390/vaccines13030263.
7
COVID-19 clinical presentation, management, and epidemiology: a concise compendium.新型冠状病毒肺炎的临床表现、治疗与流行病学:简明概要
Front Public Health. 2025 Jan 31;13:1498445. doi: 10.3389/fpubh.2025.1498445. eCollection 2025.
8
Cancer vaccines: an update on recent achievements and prospects for cancer therapy.癌症疫苗:癌症治疗近期成果与前景的最新进展
Clin Exp Med. 2024 Dec 25;25(1):24. doi: 10.1007/s10238-024-01541-7.
9
Comparative assessment of the transduction efficiency and safety associated with the delivery of AAV9-GFP vector via lumbar puncture to cynomolgus macaques with and without anti-AAV9 pre-existing antibodies.对有无预先存在抗AAV9抗体的食蟹猴经腰椎穿刺递送AAV9-GFP载体的转导效率和安全性进行比较评估。
Mol Ther Methods Clin Dev. 2024 Nov 6;32(4):101371. doi: 10.1016/j.omtm.2024.101371. eCollection 2024 Dec 12.
10
Infection-induced trained immunity: a twist in paradigm of innate host defense and generation of immunological memory.感染诱导的训练免疫:固有宿主防御范式的转变与免疫记忆的产生。
Infect Immun. 2025 Jan 31;93(1):e0047224. doi: 10.1128/iai.00472-24. Epub 2024 Dec 10.
BCG 疫苗接种史与不同医疗保健工作者人群 SARS-CoV-2 血清阳性率降低相关。
J Clin Invest. 2021 Jan 19;131(2). doi: 10.1172/JCI145157.
4
BCG Vaccination Induces Long-Term Functional Reprogramming of Human Neutrophils.BCG 疫苗接种可诱导人中性粒细胞的长期功能重编程。
Cell Rep. 2020 Nov 17;33(7):108387. doi: 10.1016/j.celrep.2020.108387.
5
Anti-viral protective capacity of tissue resident memory T cells.组织驻留记忆 T 细胞的抗病毒保护能力。
Curr Opin Virol. 2021 Feb;46:20-26. doi: 10.1016/j.coviro.2020.09.006. Epub 2020 Oct 30.
6
Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity.粒细胞生成的固有免疫训练促进抗肿瘤活性。
Cell. 2020 Oct 29;183(3):771-785.e12. doi: 10.1016/j.cell.2020.09.058.
7
Airway Macrophages Mediate Mucosal Vaccine-Induced Trained Innate Immunity against in Early Stages of Infection.气道巨噬细胞介导黏膜疫苗诱导的固有免疫记忆抵抗 感染早期。
J Immunol. 2020 Nov 15;205(10):2750-2762. doi: 10.4049/jimmunol.2000532. Epub 2020 Sep 30.
8
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护:丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
9
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.激活:卡介苗疫苗接种预防老年人感染的随机临床试验。
Cell. 2020 Oct 15;183(2):315-323.e9. doi: 10.1016/j.cell.2020.08.051. Epub 2020 Sep 1.
10
Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study.BCG 近期接种者的安全性和 COVID-19 症状:一项回顾性队列研究。
Cell Rep Med. 2020 Aug 25;1(5):100073. doi: 10.1016/j.xcrm.2020.100073. Epub 2020 Aug 5.